Ensemble-plus Study Design: An Investigation of Shortened Ocrelizumab Infusion Time on Infusion-related Reactions in Patients with Relapsing Multiple Sclerosis from the Phase Iiib Ensemble-plus Study
Titel:
Ensemble-plus Study Design: An Investigation of Shortened Ocrelizumab Infusion Time on Infusion-related Reactions in Patients with Relapsing Multiple Sclerosis from the Phase Iiib Ensemble-plus Study
Auteur:
Yamout, B. Brochet, B. Nos, C. Freedman, M.S. Killstein, J. Overell, J. Buffels, R. Fitovski, K. Mehta, L. Wang, Q. Hartung, H.